Immix Biopharma, Inc. (ImmixBio™) is a clinical-stage biopharmaceutical company pioneering a novel class of Tissue-Specific Therapeutics (TSTx)™ in oncology and inflammation.

Biotechnology

Immix Biopharma

Immix Biopharma's headquarters in Los Angeles, CA, United States

Ilya Rachman

Graham Ross

Michael Grabow

Gabriel Morris

Carey Ng

Jane Buchan

Magda Marquet

Sean Senn

Larry Norton

Sant Chawla

Razelle Kurzrock

Vladimir Torchilin

Jason Hsu

Helen C. Adams

Gary Schiller

George W. Sledge

This department manages and oversees the planning, execution, and analysis of clinical trials to ensure they are conducted efficiently and according to regulatory standards.

Clinical Operations

The Scientific Advisory Team at Immix Biopharma provides strategic guidance and expert insights on the development of Tissue-Specific Therapeutics (TSTx)™. They advise on clinical trials, research methodologies, and scientific innovations in oncology and inflammation to support the company's mission and ensure the potential for therapeutic breakthroughs.

Scientific Advisory Team

This department focuses on the development and analysis of artificial intelligence technologies and applications.

Artificial Intelligence

This department oversees the strategic direction and governance of the organization through its board members.

Board Governance

This department conducts and oversees clinical trials to gather data on the safety and efficacy of medical treatments.

Clinical Research

This department focuses on driving business growth through effective marketing, market access, and commercial operations.

Immix Biopharma

Org chart

Board & advisors

Teams

Clinical Operations

Scientific Advisory Team

Artificial Intelligence

Board Governance

Clinical Research

Commercial Strategy

Offices

Immix Biopharma

Org chart

Board & advisors

Teams

Clinical Operations

Scientific Advisory Team

Artificial Intelligence

Board Governance

Clinical Research

Commercial Strategy

Offices

Related companies